A three-year-old boy, Oliver Chu, becomes the first patient in the world to receive a revolutionary gene therapy for Hunter syndrome, a rare genetic disorder. After the groundbreaking treatment in Manchester, doctors report astonishing progress in his physical and cognitive development, offering new hope for children with rare diseases.
